Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Consumption of a Bifidobacterium bifidum Strain for 4 Weeks Modulates Dominant Intestinal Bacterial Taxa and Fecal Butyrate in Healthy Adults. β
Go to Publication β
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 82 Issue 19 Pages: 5850-9 Pub: 2016 Oct 1 Epub: 2016 Sep 16 Authors Gargari G , Taverniti V , Balzaretti S , Ferrario C , Gardana C , Simonetti P , Guglielmetti S , |
|
|
Potential of Lactobacillus plantarum ZDY2013 and Bifidobacterium bifidum WBIN03 in relieving colitis by gut microbiota, immune, and anti-oxidative stress. β
Go to Publication β
Canadian journal of microbiology (Can J Microbiol ) Vol: Issue Pages: 1-11 Pub: 2018 Feb 5 Epub: 2018 Feb 5 Authors Wang Y , Guo Y , Chen H , Wei H , Wan C , |
|
|
Bifidobacterium bifidum TMC3115 Can Characteristically Influence Glucose and Lipid Profile and Intestinal Microbiota in the Middle-Aged and Elderly. β
Go to Publication β
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2018 Jul 5 Epub: 2018 Jul 5 Authors Wang K , Yu X , Li Y , Guo Y , Ge L , Pu F , Ma X , Cui W , Marrota F , He F , Li M , |
|
|
Bifidobacterium bifidum TMC3115 Can Characteristically Influence Glucose and Lipid Profile and Intestinal Microbiota in the Middle-Aged and Elderly. β
Go to Publication β
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2018 Jul 5 Epub: 2018 Jul 5 Authors Wang K , Yu X , Li Y , Guo Y , Ge L , Pu F , Ma X , Cui W , Marrota F , He F , Li M , |
|
|
Bifidobacterium bifidum TMC3115 Can Characteristically Influence Glucose and Lipid Profile and Intestinal Microbiota in the Middle-Aged and Elderly. β
Go to Publication β
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2018 Jul 5 Epub: 2018 Jul 5 Authors Wang K , Yu X , Li Y , Guo Y , Ge L , Pu F , Ma X , Cui W , Marrota F , He F , Li M , |
|
|
Bifidobacterium bifidum TMC3115 ameliorates milk protein allergy in by affecting gut microbiota: A randomized double-blind control trial. β
Go to Publication β
Journal of food biochemistry (J Food Biochem ) Vol: 44 Issue 11 Pages: e13489 Pub: 2020 Nov Epub: 2020 Sep 29 Authors Jing W , Liu Q , Wang W , |
|
|
Bifidobacterium bifidum TMC3115 ameliorates milk protein allergy in by affecting gut microbiota: A randomized double-blind control trial. β
Go to Publication β
Journal of food biochemistry (J Food Biochem ) Vol: 44 Issue 11 Pages: e13489 Pub: 2020 Nov Epub: 2020 Sep 29 Authors Jing W , Liu Q , Wang W , |
|
|
Bifidobacterium bifidum TMC3115 ameliorates milk protein allergy in by affecting gut microbiota: A randomized double-blind control trial. β
Go to Publication β
Journal of food biochemistry (J Food Biochem ) Vol: 44 Issue 11 Pages: e13489 Pub: 2020 Nov Epub: 2020 Sep 29 Authors Jing W , Liu Q , Wang W , |
|
|
Bifidobacterium bifidum TMC3115 ameliorates milk protein allergy in by affecting gut microbiota: A randomized double-blind control trial. β
Go to Publication β
Journal of food biochemistry (J Food Biochem ) Vol: 44 Issue 11 Pages: e13489 Pub: 2020 Nov Epub: 2020 Sep 29 Authors Jing W , Liu Q , Wang W , |
|
|
Bifidobacterium bifidum TMC3115 ameliorates milk protein allergy in by affecting gut microbiota: A randomized double-blind control trial. β
Go to Publication β
Journal of food biochemistry (J Food Biochem ) Vol: 44 Issue 11 Pages: e13489 Pub: 2020 Nov Epub: 2020 Sep 29 Authors Jing W , Liu Q , Wang W , |
|
|
Bifidobacterium bifidum Shows More Diversified Ways of Relieving Non-Alcoholic Fatty Liver Compared with Bifidobacterium adolescentis. β
Go to Publication β
Biomedicines (Biomedicines ) Vol: 10 Issue 1 Pages: Pub: 2021 Dec 31 Epub: 2021 Dec 31 Authors Wang L , Jiao T , Yu Q , Wang J , Wang L , Wang G , Zhang H , Zhao J , Chen W , |
|
|
Bifidobacterium bifidum Shows More Diversified Ways of Relieving Non-Alcoholic Fatty Liver Compared with Bifidobacterium adolescentis. β
Go to Publication β
Biomedicines (Biomedicines ) Vol: 10 Issue 1 Pages: Pub: 2021 Dec 31 Epub: 2021 Dec 31 Authors Wang L , Jiao T , Yu Q , Wang J , Wang L , Wang G , Zhang H , Zhao J , Chen W , |
|
|
Heat-Killed Bifidobacterium bifidum B1628 May Alleviate Dextran Sulfate Sodium-Induced Colitis in Mice, and the Anti-Inflammatory Effect Is Associated with Gut Microbiota Modulation. β
Go to Publication β
Nutrients (Nutrients ) Vol: 14 Issue 24 Pages: Pub: 2022 Dec 8 Epub: 2022 Dec 8 Authors Feng C , Zhang W , Zhang T , He Q , Kwok LY , Tan Y , Zhang H , |
|
|
Heat-Killed Bifidobacterium bifidum B1628 May Alleviate Dextran Sulfate Sodium-Induced Colitis in Mice, and the Anti-Inflammatory Effect Is Associated with Gut Microbiota Modulation. β
Go to Publication β
Nutrients (Nutrients ) Vol: 14 Issue 24 Pages: Pub: 2022 Dec 8 Epub: 2022 Dec 8 Authors Feng C , Zhang W , Zhang T , He Q , Kwok LY , Tan Y , Zhang H , |
|
|
Heat-Killed Bifidobacterium bifidum B1628 May Alleviate Dextran Sulfate Sodium-Induced Colitis in Mice, and the Anti-Inflammatory Effect Is Associated with Gut Microbiota Modulation. β
Go to Publication β
Nutrients (Nutrients ) Vol: 14 Issue 24 Pages: Pub: 2022 Dec 8 Epub: 2022 Dec 8 Authors Feng C , Zhang W , Zhang T , He Q , Kwok LY , Tan Y , Zhang H , |
|
|
Heat-Killed Bifidobacterium bifidum B1628 May Alleviate Dextran Sulfate Sodium-Induced Colitis in Mice, and the Anti-Inflammatory Effect Is Associated with Gut Microbiota Modulation. β
Go to Publication β
Nutrients (Nutrients ) Vol: 14 Issue 24 Pages: Pub: 2022 Dec 8 Epub: 2022 Dec 8 Authors Feng C , Zhang W , Zhang T , He Q , Kwok LY , Tan Y , Zhang H , |
|
|
Early life administration of Bifidobacterium bifidum BD-1 alleviates long-term colitis by remodeling the gut microbiota and promoting intestinal barrier development. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 916824 Pub: 2022 Epub: 2022 Jul 22 Authors Peng C , Li J , Miao Z , Wang Y , Wu S , Wang Y , Wang S , Cheng R , He F , Shen X , |
|
|
Probiotics induce intestinal IgA secretion in weanling mice potentially through promoting intestinal APRIL expression and modulating the gut microbiota composition. β
Go to Publication β
Food & function (Food Funct ) Vol: 15 Issue 9 Pages: 4862-4873 Pub: 2024 May 7 Epub: 2024 May 7 Authors Zhao M , Liang X , Meng Y , Lu H , Lin K , Gong P , Liu T , Yi H , Pan J , Zhang Y , Zhang Z , Zhang L , |
|
|
Bifidobacterium improves oestrogen-deficiency-induced osteoporosis in mice by modulating intestinal immunity. β
Go to Publication β
Food & function (Food Funct ) Vol: 15 Issue 4 Pages: 1840-1851 Pub: 2024 Feb 19 Epub: 2024 Feb 19 Authors Zhang J , Liang X , Tian X , Zhao M , Mu Y , Yi H , Zhang Z , Zhang L , |
|
|
Protective effect of Bifidobacterium bifidum FSDJN7O5 and Bifidobacterium breve FHNFQ23M3 on diarrhea caused by enterotoxigenic Escherichia coli. β
Go to Publication β
Food & function (Food Funct ) Vol: 12 Issue 16 Pages: 7271-7282 Pub: 2021 Aug 21 Epub: 2021 Jun 24 Authors Yang B , Huang Z , He Z , Yue Y , Zhou Y , Ross RP , Stanton C , Zhang H , Zhao J , Chen W , |
|
|
Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice. β
Go to Publication β
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 104 Issue 13 Pages: 5915-5928 Pub: 2020 Jul Epub: 2020 May 4 Authors Wang Q , Wang K , Wu W , Lv L , Bian X , Yang L , Wang Q , Li Y , Ye J , Fang D , Wu J , Jiang X , Xie J , Lu Y , Li L , |
|
|
Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice. β
Go to Publication β
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 104 Issue 13 Pages: 5915-5928 Pub: 2020 Jul Epub: 2020 May 4 Authors Wang Q , Wang K , Wu W , Lv L , Bian X , Yang L , Wang Q , Li Y , Ye J , Fang D , Wu J , Jiang X , Xie J , Lu Y , Li L , |
|
|
Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice. β
Go to Publication β
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 104 Issue 13 Pages: 5915-5928 Pub: 2020 Jul Epub: 2020 May 4 Authors Wang Q , Wang K , Wu W , Lv L , Bian X , Yang L , Wang Q , Li Y , Ye J , Fang D , Wu J , Jiang X , Xie J , Lu Y , Li L , |
|
|
2'-Fucosyllactose synbiotics with Bifidobacterium bifidum to improve intestinal transcriptional function and gut microbiota in constipated mice. β
Go to Publication β
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 217 Issue Pages: 116840 Pub: 2025 Oct Epub: 2025 Jun 9 Authors Shan Y , Zheng M , Liang W , Ouyang L , Wang S , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
